vTv Therapeutics Inc. (VTVT) DCF Valuation

vTv Therapeutics Inc. (VTVT) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

vTv Therapeutics Inc. (VTVT) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you’re an investor or an analyst, this (VTVT) DCF Calculator is your go-to tool for accurate valuation. Preloaded with real data from vTv Therapeutics Inc., you can adjust forecasts and instantly observe the impact.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 2.8 6.4 4.0 2.0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 132.05 -37.56 -49.61 -100 -21.79 -21.79 -21.79 -21.79 -21.79
EBITDA -20.0 -12.0 -17.5 -24.8 -25.4 .0 .0 .0 .0 .0
EBITDA, % -722.58 -187.34 -437.33 -1227.25 100 -60 -60 -60 -60 -60
Depreciation .0 .1 .1 .1 .1 .0 .0 .0 .0 .0
Depreciation, % 1.41 1.47 2.22 4.56 100 21.93 21.93 21.93 21.93 21.93
EBIT -20.0 -12.1 -17.6 -24.9 -25.5 .0 .0 .0 .0 .0
EBIT, % -723.99 -188.81 -439.55 -1231.81 100 -60 -60 -60 -60 -60
Total Cash 1.8 5.7 13.4 12.1 9.4 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .2 .1 12.4 .1
Account Receivables, % 0.1809 2.46 1.42 615.26 100
Inventories .3 .4 .1 .0 .0 .0 .0 .0 .0 .0
Inventories, % 9.04 5.78 2.5 0.74331 100 23.61 23.61 23.61 23.61 23.61
Accounts Payable 2.2 1.9 1.9 2.5 4.1 .0 .0 .0 .0 .0
Accounts Payable, % 80.75 30.01 46.84 121.95 100 71.52 71.52 71.52 71.52 71.52
Capital Expenditure -.1 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -2.53 0 0 -1.04 100 -0.71464 -0.71464 -0.71464 -0.71464 -0.71464
Tax Rate, % 22.01 22.01 22.01 22.01 22.01 22.01 22.01 22.01 22.01 22.01
EBITAT -20.1 -8.3 -17.7 -25.1 -19.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -18.2 -8.8 -17.3 -36.7 -5.9 -4.0 .0 .0 .0 .0
WACC, % 7.36 7.34 7.36 7.36 7.34 7.35 7.35 7.35 7.35 7.35
PV UFCF
SUM PV UFCF -3.7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -4
Net Debt -9
Equity Value 5
Diluted Shares Outstanding, MM 2
Equity Value Per Share 2.50

What You Will Get

  • Real VTVT Financial Data: Pre-filled with vTv Therapeutics Inc.'s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See vTv Therapeutics Inc.'s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive DCF Calculator: Features both unlevered and levered DCF valuation models tailored for vTv Therapeutics Inc. (VTVT).
  • WACC Calculator: A pre-configured Weighted Average Cost of Capital sheet with adjustable parameters.
  • Customizable Forecast Assumptions: Easily alter growth rates, capital expenditures, and discount rates.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to vTv Therapeutics Inc. (VTVT).
  • Interactive Dashboard and Charts: Visual representations that encapsulate essential valuation metrics for straightforward analysis.

How It Works

  • Download: Obtain the pre-formatted Excel file containing vTv Therapeutics Inc.'s (VTVT) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC as needed.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and evaluate results immediately.
  • Make Decisions: Leverage the valuation findings to inform your investment approach.

Why Choose This Calculator for vTv Therapeutics Inc. (VTVT)?

  • User-Friendly Interface: Tailored for both novice and seasoned users.
  • Customizable Inputs: Modify assumptions effortlessly to suit your analysis needs.
  • Real-Time Valuation: Observe immediate updates to vTv Therapeutics' valuation as you adjust parameters.
  • Preloaded Data: Comes equipped with vTv Therapeutics' actual financial metrics for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive and accurate valuation models for portfolio management related to vTv Therapeutics Inc. (VTVT).
  • Pharmaceutical Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in vTv Therapeutics Inc. (VTVT).
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech companies like vTv Therapeutics Inc. (VTVT) are assessed in the financial markets.

What the Template Contains

  • Historical Data: Includes vTv Therapeutics Inc.'s past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate vTv Therapeutics Inc.'s intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of vTv Therapeutics Inc.'s financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.